LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Pig Intestines May Aid Bone Repair
Biologics

Pig Intestines May Aid Bone Repair

August 1, 2013 1 min read Premium comments

Advertisement

Pig Intestines May Aid Bone Repair
Source: Wikimedia Commons and Scott Bauer
Secondary

A California-based start-up, SMC Biotechnology, is betting that carbohydrates hold the key to rapid bone healing after surgery or a traumatic injury. Luke Timmerman, national biotech editor of Xconomy, writes that the carbohydrates that SMC Bio is betting on are variations of heparan sulfate, a long-chained sugar molecule that promotes bone healing by binding with bone morphogenic protein-2 (BMP-2). The sugar molecules come from the mucosal lining of pig intestines, just as does the blood-thinning agent heparin.

SMC Co-Founder and CEO Michael Crockett got the idea from the laboratory of Simon Cool and Victor Nurcome in Singapore’s A*STAR research center. The role of BMP-2 in healing bones after an injury was well known, but Crockett and the researchers proposed that carbohydrates were what were missing at injury sites. The injured area was already flooded with the BMP-2 growth factor. By adding carbohydrates to the site of the injury the bone-healing signals coming from the BMP-2 and stem cells would be enhanced, they proposed.

SMC’s plan is to put the heparan sulfate variants from the pig intestines on a collagen sponge that a doctor can place at a wound site during back surgery, or any procedure to repair broken bones. The technology is classified as a medical device rather than as a drug for FDA regulatory purposes.

SMC has completed tests on rabbits which Crockett judged successful. The company is planning a clinical trial in 2014 on sheep to confirm the results in heavier animals. “Instead of injecting growth factors or stem cells in the body, we’re using what’s already there, ” Crockett told Timmerman. “We’re just enhancing the body’s natural process, enhancing bone healing.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy